The superfamily of heme-thiolate proteins known as the cytochromes P45
0 if responsible for the oxidative metabolism of the majority of drugs
. Thus, the phenotypes of individuals with respect to their levels of
catalytically active cytochromes P450 determines to a large part the s
ubstantial interindividual variation observed in the metabolic clearan
ce of drugs. Over the past IO years IS different human cytochromes P45
0 involved in drug metabolism have been isolated and characterized to
varying degrees. This brief review discusses the characterization of t
hese cytochromes P450 and how this knowledge has been used by the phar
maceutical industry to aid in the development of new drugs.